Skip to main content

Table 3 Comparison of C-index for our model and FIGO2018 stage system

From: A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy

Group

Nomogram

(95%CI)

FIGO2018

(95%CI)

Training set

0.74 (0.67–0.80)

0.66 (0.59–0.73)

Validation set

0.70 (0.57–0.82)

0.63 (0.52–0.75)

  1. FIGO International Federation of Gynecology and Obstetrics